99mTc-rituximab tracer injection for guiding internal mammary sentinel lymph nodes biopsy in primary breast cancer: A prospective observational study

被引:0
|
作者
Chen, Wenxin [1 ,2 ,3 ]
Su, Yaodong [1 ,2 ,3 ]
Zhang, Hui [4 ,5 ]
Zhang, Yu [1 ,2 ,3 ]
Zhu, Lin [6 ,7 ]
Lin, Mengbo [4 ,5 ]
Lin, Zhiyi [1 ,2 ,3 ]
Yu, Mingdian [2 ]
Yang, Shengping [2 ]
Zhang, Yanmin [2 ]
机构
[1] Fujian Med Univ, Dept Nucl Med, Shengli Clin Med Coll, Fuzhou, Peoples R China
[2] Fujian Prov Hosp, Dept Nucl Med, Fuzhou, Peoples R China
[3] Fujian Res Inst Nucl Med, Fuzhou, Peoples R China
[4] Fujian Med Univ, Dept Oncol Surg, Shengli Clin Med Coll, Fuzhou, Peoples R China
[5] Fujian Prov Hosp, Dept Oncol Surg, Fuzhou, Peoples R China
[6] Fujian Med Univ, Dept Ultrason Diagnost, Shengli Clin Med Coll, Fuzhou, Peoples R China
[7] Fujian Prov Hosp, Dept Ultrason Diagnost, Fuzhou, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词
breast cancer; Tc-99m-rituximab; sentinel lymph node; internal mammary lymph node; single photon emission computed tomography; computed tomography; biopsy; IRRADIATION; MANAGEMENT;
D O I
10.3389/fonc.2023.1100077
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveTo explore the use of Tc-99m-rituximab tracer injection for internal mammary sentinel lymph node (IM-SLN) detection in patients with primary breast cancer. MethodsThis prospective observational study enrolled female patients with primary breast cancer between September 2017 and June 2022 at Fujian Provincial Hospital. The participants were divided into the peritumoral group (two subcutaneous injection points on the surface of the tumor), two-site group (injections into the glands at 6 and 12 o'clock around the areola area), and four-site group (injections into the gland at 3, 6, 9, and 12 o'clock around the areola area). The outcomes were the detection rates of the IM-SLNs and axillary sentinel lymph nodes (A-SLNs). ResultsFinally, 133 patients were enrolled, including 53 in the peritumoral group, 60 in the two-site group, and 20 in the four-site group. The detection rate of the IM-SLNs in the peritumoral group (9.4% [5/53]) was significantly lower than in the two-site (61.7% [37/60], P<0.001) and four-site (50.0% [10/20], P<0.001) groups. The detection rates of A-SLNs among the three groups were comparable (P=0.436). ConclusionThe two-site or four-site intra-gland injection of Tc-99m-rituximab tracer might achieve a higher detection rate of IM-SLNs and a comparable detection rate of A-SLNs compared with the peritumoral method. The location of the primary focus has no impact on the detection rate of the IM-SLNs.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] 99mTc-Rituximab sentinel lymph node mapping and biopsy, the effective technique avoids axillary dissection and predicts prognosis in 533 cutaneous melanoma
    Nan Li
    Xin Zhou
    Hua Zhu
    Fei Wang
    Rui Guo
    Yan Zhang
    Yufei Song
    Shizhen Zhai
    Qing Xie
    Jiayong Liu
    Zhongwu Li
    Zhi Yang
    Annals of Nuclear Medicine, 2023, 37 : 189 - 197
  • [22] Sentinel lymph node biopsy in breast cancer: importance of the internal mammary chain
    Noterman, D
    Bourgeois, P
    Hertens, D
    Veys, I
    Larsimont, D
    Nogaret, JM
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S63 - S63
  • [23] A selection algorithm for internal mammary sentinel lymph node biopsy in breast cancer
    Bevilacqua, JLB
    Gucciardo, G
    Cody, HS
    MacDonald, KA
    Sacchini, V
    Borgen, PI
    Van Zee, KJ
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2002, 28 (06): : 603 - 614
  • [24] Unresolved issues in internal mammary sentinel lymph node biopsy for breast cancer
    Noguchi M.
    Breast Cancer, 2002, 9 (2) : 91 - 94
  • [25] Halsted revisited: Internal mammary sentinel lymph node biopsy in breast cancer
    van der Ent, FWC
    Kengen, RAM
    van der Pol, HAG
    Povel, JACM
    Stroeken, HJG
    Hoofwijk, AGM
    ANNALS OF SURGERY, 2001, 234 (01) : 79 - 84
  • [26] Internal mammary lymph drainage and sentinel node biopsy in breast cancer - A study on 1008 patients
    Heuts, E. M.
    van der Ent, F. W. C.
    von Meyenfeldt, M. F.
    Voogd, A. C.
    EJSO, 2009, 35 (03): : 252 - 257
  • [27] Comparative research on99mTc-rituximab and 99mTc-sulfur colloid in sentinel lymph nodemappingof breast cancer
    Zhang, Jingjie
    Zhang, Wanchun
    Li, Xiaomin
    Ma, Le
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [28] Internal mammary lymph drainage and sentinel node biopsy in breast cancer - a study on 1008 patients
    Heuts, E.
    van der Ent, F. W. C.
    von Meyenfeldt, M. F.
    Voogd, A. C.
    EJC SUPPLEMENTS, 2008, 6 (07): : 98 - 98
  • [29] Sentinel Lymph Node Biopsy in Breast Cancer with 99mTc-Tilmanocept: A Multicenter Study on Real-Life Use of a Novel Tracer
    Vidal-Sicart, Sergi
    Eugenia Rioja, Maria
    Prieto, Andrea
    Goni, Elena
    Gomez, Isabel
    Dolores Albala, Maria
    Lumbreras, Luis
    Fernanda Leon, Luisa
    Ramon Gomez, Jose
    Campos, Francisco
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (05) : 620 - 627
  • [30] 99mTc-Rituximab sentinel lymph node mapping and biopsy, the effective technique avoids axillary dissection and predicts prognosis in 533 cutaneous melanoma
    Li, Nan
    Zhou, Xin
    Zhu, Hua
    Wang, Fei
    Guo, Rui
    Zhang, Yan
    Song, Yufei
    Zhai, Shizhen
    Xie, Qing
    Liu, Jiayong
    Li, Zhongwu
    Yang, Zhi
    ANNALS OF NUCLEAR MEDICINE, 2023, 37 (03) : 189 - 197